buthionine sulfoximine glutathione (BSO) decreases intracellular (GSH) resistant human breast cancer cells Sigma-Aldrich ʟ-Buthionine-sulfoximine, CAS 83730-53-4, ≥97%
Sigma Aldrich Buthionine sulfoximine, CAS 83730 53 4, 97% (TLC) 500 mg Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L buthionine sulfoximine Cell Death & Differentiation Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor 2 Expressing Pre Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu DOTATATE The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Blood Cancer Journal
Pay in 4 interest-free payments of $6.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



